Portfolio Holdings Detail for ISIN IE00BZ0PKS76
Stock Name / FundiShares Edge MSCI USA Multifactor UCITS
IssuerBlackrock
Entity holding fund iShares IV Public Limited Company
Entity TypeUmbrella investment company with variable capital and having segregated liability between its funds
Entity LEI 549300ZP07LMR36K1T02
ETF TickerFSUS(GBX) LSE
ETF TickerIBCY(EUR) F
ETF TickerIBCY.DE(EUR) CXE
ETF TickerIFSU.MI(EUR) CXE
ETF TickerIFSU(EUR) ETF Plus
ETF TickerFSUS.L(GBP) LSE

Holdings detail for ABT

Stock NameAbbott Laboratories
TickerABT(USD) NYSE
TYPECommon Stock
CountryUSA
ISINUS0028241000
LEIHQD377W2YR662HK5JX27

Show aggregate ABT holdings

News associated with ABT

Bank of America Increases Abbott Laboratories (NYSE:ABT) Price Target to $150.00
Abbott Laboratories (NYSE:ABT – Get Free Report) had its target price upped by equities research analysts at Bank of America from $133.00 to $150.00 in a report released on Monday,Benzinga reports. The brokerage currently has a “buy” rating on the healthcare product maker’s stock. Bank of America‘s target price would indicate a potential upside of […] - 2025-03-12 06:08:55
Congressmember Shelley Moore Capito's New Portfolio Holdings
Quiver's Shelley Moore Capito Strategy is an automated trading strategy that tracks the performance of stocks that are being held by U.S. Congressmember Shelley Moore Capito (or their family).This strategy is rebalanced when new trades or annual reports are reported. The strategy - 2025-03-07 20:00:07
Sen. Shelley Moore Capito Sells Abbott Laboratories (NYSE:ABT) Shares
Senator Shelley Moore Capito (R-West Virginia) recently sold shares of Abbott Laboratories (NYSE:ABT). In a filing disclosed on March 06th, the Senator disclosed that they had sold between $1,001 and $15,000 in Abbott Laboratories stock on February 24th. Senator Shelley Moore Capito also recently made the following trade(s): Sold $1,001 – $15,000 in shares of […] - 2025-03-07 07:06:55
Abbott Laboratories (NYSE:ABT) Reaches New 52-Week High Following Analyst Upgrade
Abbott Laboratories (NYSE:ABT – Get Free Report)’s share price reached a new 52-week high during trading on Wednesday after Citigroup raised their price target on the stock from $135.00 to $160.00. Citigroup currently has a buy rating on the stock. Abbott Laboratories traded as high as $141.23 and last traded at $137.65, with a volume […] - 2025-03-06 08:08:01
Is Medtronic Stock Underperforming the Nasdaq?
Medtronic has underperformed the Nasdaq over the past year, but analysts are moderately optimistic about the stock’s prospects. - 2025-03-05 18:47:11
Citigroup Issues Positive Forecast for Abbott Laboratories (NYSE:ABT) Stock Price
Abbott Laboratories (NYSE:ABT – Free Report) had its price target lifted by Citigroup from $135.00 to $160.00 in a research note issued to investors on Tuesday,Benzinga reports. They currently have a buy rating on the healthcare product maker’s stock. Several other analysts also recently weighed in on the stock. Barclays reissued an “overweight” rating and […] - 2025-03-05 10:06:53
Intuitive Surgical Stock: Is ISRG Outperforming the Healthcare Sector?
Intuitive Surgical's robust outperformance against the healthcare sector over the past year has reinforced Wall Street analysts' bullish outlook on the stock. - 2025-03-04 14:51:24
Stock Traders Buy High Volume of Call Options on Abbott Laboratories (NYSE:ABT)
Abbott Laboratories (NYSE:ABT – Get Free Report) was the target of some unusual options trading on Monday. Stock investors acquired 22,017 call options on the company. This is an increase of 73% compared to the average daily volume of 12,690 call options. Abbott Laboratories Stock Up 1.5 % Abbott Laboratories stock opened at $140.13 on […] - 2025-03-04 08:44:54
XLV, ABT, TMO, PFE: Large Inflows Detected at ETF
Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the The Health Care Select Sector SPDR Fund (Symbol: XLV) where we have detected an approximate $849.0 million dollar inflow -- that's a 2.2% increase we - 2025-03-03 16:08:05
Is Abbott Laboratories Stock Outperforming the Dow?
Abbott Laboratories has notably outpaced the Dow Jones Industrial Average over the past year and analysts remain strongly bullish on the stock’s prospects. - 2025-03-03 14:36:49
Abbott Laboratories Reaches Analyst Target Price
In recent trading, shares of Abbott Laboratories (Symbol: ABT) have crossed above the average analyst 12-month target price of $136.09, changing hands for $138.01/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgrade on - 2025-03-03 12:47:24
Is Abbott Laboratories Stock Outperforming the Dow?
Abbott Laboratories has notably outpaced the Dow Jones Industrial Average over the past year and analysts remain strongly bullish on the stock’s prospects. - 2025-03-03 10:45:41
Insulet Stock Outlook: Is Wall Street Bullish or Bearish?
Insulet has outperformed the broader market over the past year, and analysts are highly optimistic about the stock’s prospects. - 2025-02-25 14:31:50
2,792 Shares in Abbott Laboratories (NYSE:ABT) Acquired by Strategic Financial Concepts LLC
Strategic Financial Concepts LLC purchased a new position in shares of Abbott Laboratories (NYSE:ABT – Free Report) during the 4th quarter, according to its most recent 13F filing with the SEC. The firm purchased 2,792 shares of the healthcare product maker’s stock, valued at approximately $316,000. Other institutional investors and hedge funds have also bought […] - 2025-02-21 09:41:02
Congressmember Shelley Moore Capito's New Portfolio Holdings
Quiver's Shelley Moore Capito Strategy is an automated trading strategy that tracks the performance of stocks that are being held by U.S. Congressmember Shelley Moore Capito (or their family).This strategy is rebalanced when new trades or annual reports are reported. The strategy - 2025-02-14 20:00:07
Noteworthy ETF Inflows: SPXL, ABT, MCD, DIS
Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the Direxion Daily S&P 500 Bull 3X (Symbol: SPXL) where we have detected an approximate $252.9 million dollar inflow -- that's a 5.1% increase week o - 2025-02-13 15:49:29
Fund Update: Applied Finance Capital Management, LLC Just Disclosed New Holdings
Applied Finance Capital Management, LLC just filed a portfolio update, which we received from a 13F disclosure. This disclosure reflects the funds' holdings for the 12-31-2024 report period. You can see the full portfolio on Quiver Quantitative, and track moves made by other fun - 2025-02-13 15:04:32
Strategic Financial Concepts LLC Purchases Shares of 272,961 Abbott Laboratories (NYSE:ABT)
Strategic Financial Concepts LLC acquired a new position in shares of Abbott Laboratories (NYSE:ABT – Free Report) during the fourth quarter, HoldingsChannel reports. The firm acquired 272,961 shares of the healthcare product maker’s stock, valued at approximately $316,000. Several other institutional investors have also added to or reduced their stakes in ABT. Groupama Asset Managment […] - 2025-02-13 09:02:56
Fund Update: B. Metzler seel. Sohn & Co. AG Just Disclosed New Holdings
B. Metzler seel. Sohn & Co. AG just filed a portfolio update, which we received from a 13F disclosure. This disclosure reflects the funds' holdings for the 12-31-2024 report period. You can see the full portfolio on Quiver Quantitative, and track moves made by other funds. - 2025-02-12 18:13:07
Congress Trade: Representative Emily Randall Just Disclosed New Stock Trades
Representative Emily Randall just filed new stock trades, which we received from a STOCK Act disclosure. You can see the full list of trades on Quiver Quantitative's congress trading dashboard, and track the portfolios of Representative Emily Randall and other politicians. - 2025-02-12 14:37:37
Abbott Laboratories (NYSE:ABT) Upgraded at StockNews.com
StockNews.com upgraded shares of Abbott Laboratories (NYSE:ABT – Free Report) from a buy rating to a strong-buy rating in a research note issued to investors on Tuesday. ABT has been the subject of a number of other research reports. UBS Group increased their price objective on shares of Abbott Laboratories from $146.00 to $148.00 and […] - 2025-02-07 08:37:16
Abbott Laboratories Sees Unusually High Options Volume (NYSE:ABT)
Abbott Laboratories (NYSE:ABT – Get Free Report) was the recipient of some unusual options trading on Wednesday. Traders bought 26,157 call options on the stock. This represents an increase of 116% compared to the typical daily volume of 12,104 call options. Analyst Upgrades and Downgrades ABT has been the subject of several research reports. Stifel […] - 2025-02-07 06:47:04
Noteworthy Wednesday Option Activity: WDAY, ABT, JNPR
Among the underlying components of the S&P 500 index, we saw noteworthy options trading volume today in Workday Inc (Symbol: WDAY), where a total of 8,287 contracts have traded so far, representing approximately 828,700 underlying shares. That amounts to about 42.2% of WDAY - 2025-02-05 19:25:44
iShares Core Conservative Allocation ETF Experiences Big Outflow
Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the iShares Core Conservative Allocation ETF (Symbol: AOK) where we have detected an approximate $69.7 million dollar outflow -- that's a 10.2% decrease - 2025-02-04 16:10:52
After Hours Most Active for Jan 28, 2025 : NVDA, INTC, AAPL, ABT, SCHW, T, HPE, SBUX, MCHI, BSX, CSCO, TEVA
The NASDAQ 100 After Hours Indicator is down -14.32 to 21,448.72. The total After hours volume is currently 109,434,312 shares traded.The following are the most active stocks for the after hours session: NVIDIA Corporation (NVDA) is -0.63 at $128.36, with 5,694,273 shares traded - 2025-01-28 21:24:59
The Zacks Analyst Blog Highlights Cisco Systems, Abbott Laboratories and Coca-Cola
Cisco Systems, Abbott Laboratories and Coca-Cola are part of the Zacks top Analyst Blog. - 2025-01-27 18:48:00
Top Stock Reports for Cisco, Abbott & Coca-Cola
Today's Research Daily features new research reports on 16 major stocks, including Cisco Systems, Inc. (CSCO), Abbott Laboratories (ABT) and The Coca-Cola Company (KO). - 2025-01-24 21:21:00
Congress Trade: Representative Thomas H. Kean, Jr. Just Disclosed New Stock Trades
Representative Thomas H. Kean, Jr. just filed new stock trades, which we received from a STOCK Act disclosure. You can see the full list of trades on Quiver Quantitative's congress trading dashboard, and track the portfolios of Representative Thomas H. Kean, Jr. and other politic - 2025-01-23 16:31:21

iShares Edge MSCI USA Multifactor UCITS ABT holdings

DateNumber of ABT Shares HeldBase Market Value of ABT SharesLocal Market Value of ABT SharesChange in ABT Shares HeldChange in ABT Base ValueCurrent Price per ABT Share HeldPrevious Price per ABT Share Held
2025-03-11 (Tuesday)840USD 111,434ABT holding decreased by -3948USD 111,4340USD -3,948 USD 132.66 USD 137.36
2025-03-10 (Monday)840USD 115,382ABT holding increased by 184USD 115,3820USD 184 USD 137.36 USD 137.14
2025-03-07 (Friday)840USD 115,198ABT holding decreased by -478USD 115,1980USD -478 USD 137.14 USD 137.71
2025-03-05 (Wednesday)840USD 115,676ABT holding increased by 109USD 115,6760USD 109 USD 137.71 USD 137.58
2025-03-04 (Tuesday)840USD 115,567ABT holding decreased by -2218USD 115,5670USD -2,218 USD 137.58 USD 140.22
2025-03-03 (Monday)840USD 117,785ABT holding increased by 1857USD 117,7850USD 1,857 USD 140.22 USD 138.01
2025-02-28 (Friday)840USD 115,928ABT holding increased by 1797USD 115,9280USD 1,797 USD 138.01 USD 135.87
2025-02-27 (Thursday)840USD 114,131ABT holding decreased by -75USD 114,1310USD -75 USD 135.87 USD 135.96
2025-02-26 (Wednesday)840USD 114,206ABT holding increased by 117USD 114,2060USD 117 USD 135.96 USD 135.82
2025-02-25 (Tuesday)840USD 114,089ABT holding increased by 731USD 114,0890USD 731 USD 135.82 USD 134.95
2025-02-24 (Monday)840USD 113,358ABT holding increased by 25USD 113,3580USD 25 USD 134.95 USD 134.92
2025-02-21 (Friday)840USD 113,333ABT holding increased by 1470USD 113,3330USD 1,470 USD 134.92 USD 133.17
2025-02-20 (Thursday)840USD 111,863ABT holding increased by 874USD 111,8630USD 874 USD 133.17 USD 132.13
2025-02-19 (Wednesday)840USD 110,989ABT holding increased by 1638USD 110,9890USD 1,638 USD 132.13 USD 130.18
2025-02-18 (Tuesday)840USD 109,351ABT holding decreased by -361USD 109,3510USD -361 USD 130.18 USD 130.61
2025-02-17 (Monday)840USD 109,712USD 109,7120USD 0 USD 130.61 USD 130.61
2025-02-14 (Friday)840USD 109,712ABT holding decreased by -992USD 109,7120USD -992 USD 130.61 USD 131.79
2025-02-13 (Thursday)840USD 110,704ABT holding increased by 1092USD 110,7040USD 1,092 USD 131.79 USD 130.49
2025-02-12 (Wednesday)840USD 109,612ABT holding decreased by -798USD 109,6120USD -798 USD 130.49 USD 131.44
2025-02-11 (Tuesday)840USD 110,410ABT holding increased by 110USD 110,4100USD 110 USD 131.44 USD 131.31
2025-02-10 (Monday)840USD 110,300ABT holding increased by 1881USD 110,3000USD 1,881 USD 131.31 USD 129.07
2025-02-07 (Friday)840USD 108,419ABT holding increased by 714USD 108,4190USD 714 USD 129.07 USD 128.22
2025-02-06 (Thursday)840USD 107,705ABT holding decreased by -3225USD 107,7050USD -3,225 USD 128.22 USD 132.06
2025-02-05 (Wednesday)840USD 110,930ABT holding increased by 2486USD 110,9300USD 2,486 USD 132.06 USD 129.1
2025-02-04 (Tuesday)840USD 108,444ABT holding increased by 546USD 108,4440USD 546 USD 129.1 USD 128.45
2025-02-03 (Monday)840USD 107,898ABT holding increased by 437USD 107,8980USD 437 USD 128.45 USD 127.93
2025-01-31 (Friday)840USD 107,461ABT holding decreased by -739USD 107,4610USD -739 USD 127.93 USD 128.81
2025-01-30 (Thursday)840USD 108,200ABT holding increased by 798USD 108,2000USD 798 USD 128.81 USD 127.86
2025-01-29 (Wednesday)840USD 107,402ABT holding increased by 394USD 107,4020USD 394 USD 127.86 USD 127.39
2025-01-28 (Tuesday)840USD 107,008ABT holding decreased by -1713USD 107,0080USD -1,713 USD 127.39 USD 129.43
2025-01-27 (Monday)840USD 108,721ABT holding increased by 3696USD 108,7210USD 3,696 USD 129.43 USD 125.03
2025-01-24 (Friday)840USD 105,025ABT holding increased by 1520USD 105,0250USD 1,520 USD 125.03 USD 123.22
2025-01-23 (Thursday)840USD 103,505ABT holding increased by 4570USD 103,5050USD 4,570 USD 123.22 USD 117.78
2025-01-22 (Wednesday)840USD 98,935USD 98,935
2025-01-21 (Tuesday)840USD 98,104USD 98,104
Share price and value of shares held is calculated on the adjusted close price of each day (row). Changes between days reflect the gain/loss of the portfolio as a result of changes in the adjusted close price and changes in the holdings

Share Trades of ABT by Blackrock for IE00BZ0PKS76

Show aggregate share trades of ABT

DateActionQuantityMarket HighMarket LowLikely Trade PriceLikely Trade Value (Profit/Loss)Average Price previous trades
Market high and low price is on the date.

* (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection

The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close

Shorting History of ABT

DateShorted VolumeShort Exempt VolumeTotal Shares Traded% Shorted
2025-03-12990,1607912,592,98238.2%
2025-03-111,432,0384042,978,31148.1%
2025-03-101,101,3632,0263,107,37635.4%
2025-03-071,088,3481,4523,118,33734.9%
2025-03-061,157,0262,6844,213,03727.5%
2025-03-051,441,8831,0432,931,11049.2%
2025-03-04867,3371,2773,359,98225.8%
2025-03-031,637,2301,7273,036,52953.9%
2025-02-281,201,9801,7282,880,83641.7%
2025-02-27926,2808532,252,11141.1%
2025-02-261,175,2763,7512,083,94356.4%
2025-02-251,118,0293,4132,227,39050.2%
2025-02-24968,2907,3132,545,17538.0%
2025-02-211,244,5721,5222,213,72856.2%
2025-02-20834,2281451,510,15255.2%
2025-02-19754,0441,3701,488,51850.7%
2025-02-181,026,1591,8951,533,37266.9%
2025-02-14762,803311,165,79865.4%
2025-02-13860,0706501,453,12359.2%
2025-02-121,122,5056791,864,53560.2%
2025-02-111,279,366672,125,12260.2%
2025-02-101,444,28811,4062,057,45370.2%
2025-02-071,114,16240,8541,729,73664.4%
2025-02-061,133,5323,4052,499,92145.3%
2025-02-051,873,1384,6553,280,18357.1%
2025-02-041,220,6812743,225,37037.8%
2025-02-03971,6411,1451,844,89652.7%
2025-01-31952,2556812,229,33342.7%
2025-01-301,099,3251242,472,28944.5%
2025-01-291,382,2431,2442,700,18151.2%
2025-01-282,059,3142,6434,267,89248.3%
2025-01-271,909,1293,2944,289,69444.5%
2025-01-242,054,0865,2704,285,67047.9%
2025-01-232,404,1633,0025,012,39148.0%
2025-01-222,619,5808554,946,79353.0%
2025-01-211,620,1368523,304,93449.0%
2025-01-17945,6775171,671,10656.6%
2025-01-16835,0961,3671,912,13743.7%
2025-01-15896,1084,6782,319,31038.6%
2025-01-14888,8083,8301,451,05661.3%
2025-01-13941,2321,0101,452,04964.8%
2025-01-101,137,4222,6771,826,91962.3%
2025-01-08852,3491,7591,359,88562.7%
2025-01-07655,9281971,425,66646.0%
2025-01-06637,4346,5561,484,89042.9%

The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.

Back to Listing

Disclaimer

All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability for the reliability or accuracy of the data provided. We are not making recommendations for any financial instruments listed on this website.